Moreover, the MPL expression in every type of progenitor was inversely correlated to the progressive phases of disease (Fig. S1B), indicating that the regulatory hindrance in activating MPL signaling in progenitors drove the malignant transformation in CML progression. This evidence concerns the gene MPL and chronic myelogenous leukemia, BCR-ABL1 positive.